These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1422391)

  • 1. Transferring myoblasts in Duchenne dystrophy.
    Dubowitz V
    BMJ; 1992 Oct; 305(6858):844-5. PubMed ID: 1422391
    [No Abstract]   [Full Text] [Related]  

  • 2. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 3. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.
    Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM
    Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and proliferation of human myoblasts isolated with fluorescence activated cell sorting.
    Blau HM; Webster C; Pavlath GK
    Adv Exp Med Biol; 1990; 280():97-100. PubMed ID: 2248160
    [No Abstract]   [Full Text] [Related]  

  • 5. Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy.
    Huard J; Bouchard JP; Roy R; Labrecque C; Dansereau G; Lemieux B; Tremblay JP
    Clin Sci (Lond); 1991 Aug; 81(2):287-8. PubMed ID: 1653675
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies.
    Mendell JR
    Adv Exp Med Biol; 1990; 280():287-95. PubMed ID: 2248150
    [No Abstract]   [Full Text] [Related]  

  • 7. Plausible structural/functional/behavioral/biochemical transformations following myoblast transfer therapy.
    Law PK; Goodwin TG; Li HJ; Chen M
    Adv Exp Med Biol; 1990; 280():241-9; discussion 249-50. PubMed ID: 2248145
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible.
    Roy R; Tremblay JP; Huard J; Richards C; Malouin F; Bouchard JP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):995-7. PubMed ID: 8442296
    [No Abstract]   [Full Text] [Related]  

  • 9. The principles and practice of myoblast transfer.
    Karpati G
    Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156
    [No Abstract]   [Full Text] [Related]  

  • 10. Myoblast transplantation.
    Law PK
    Science; 1992 Sep; 257(5075):1329; author reply 1329-30. PubMed ID: 1529326
    [No Abstract]   [Full Text] [Related]  

  • 11. Invited review: myoblast transfer: a possible therapy for inherited myopathies?
    Partridge TA
    Muscle Nerve; 1991 Mar; 14(3):197-212. PubMed ID: 2041542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoblast transfer in Duchenne muscular dystrophy.
    Karpati G; Ajdukovic D; Arnold D; Gledhill RB; Guttmann R; Holland P; Koch PA; Shoubridge E; Spence D; Vanasse M
    Ann Neurol; 1993 Jul; 34(1):8-17. PubMed ID: 8517684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dilemma of manifesting carriers in the context of myoblast transplantation.
    Kunkel LM
    Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy for Duchenne dystrophy.
    Engel AG
    Ann Neurol; 1993 Jul; 34(1):3-4. PubMed ID: 8517677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Can muscular dystrophy be treated?].
    Somer H
    Duodecim; 1992; 108(6):575-7. PubMed ID: 1366117
    [No Abstract]   [Full Text] [Related]  

  • 16. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biochemical determinations in the pre-transplant workup and in the post-transplant assessment period.
    Worton RG; Bulman DE; Zubrzycka-Gaarn EE; Ray PN
    Adv Exp Med Biol; 1990; 280():219-25; discussion 225-6. PubMed ID: 2248141
    [No Abstract]   [Full Text] [Related]  

  • 18. Issues in myoblast transfer.
    Brooke MH
    Adv Exp Med Biol; 1990; 280():231-3. PubMed ID: 2248143
    [No Abstract]   [Full Text] [Related]  

  • 19. Human myoblast transplantation: preliminary results of 4 cases.
    Huard J; Bouchard JP; Roy R; Malouin F; Dansereau G; Labrecque C; Albert N; Richards CL; Lemieux B; Tremblay JP
    Muscle Nerve; 1992 May; 15(5):550-60. PubMed ID: 1584246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quantitative myometry in the evaluation of myoblast transfer therapy.
    Munsat TL
    Adv Exp Med Biol; 1990; 280():227-9. PubMed ID: 2248142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.